Floatz logo

Therapeutic Asset Ratings

174 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Anti Cd30 Car-T Cell
Hodgkins Lymphoma
Zhejiang UniversityEarly P1C (34)
Humanized Cd19 Car-T Cells
Acute Lymphoblastic Leukemia
Zhejiang UniversityEarly P1C (34)
Murine Cd19 Car-T Cells
Acute Lymphoblastic Leukemia
Zhejiang UniversityEarly P1C (34)
CD117 CAR T-cells
Acute Myeloid Leukemia
Zhejiang UniversityEarly P1C (33)
cd70-targeting car-t cells
Plasma Cell Myeloma
Zhejiang UniversityEarly P1C (33)
nkg2d car t-cells
Acute Myeloid Leukemia
Zhejiang UniversityEarly P1C (33)
cg-102-12c
Hepatocellular Carcinoma
Zhejiang UniversityN/AD (30)
Cyclophosphamide
Mesothelin-positive Advanced Malignant Solid Tumors
Zhejiang UniversityN/AD (30)
DEXAMETHASONE
Gallstones
Zhejiang UniversityN/AD (30)
DEXAMETHASONE
Uterine Fibroids (Leiomyoma)
Zhejiang UniversityN/AD (30)
DROPERIDOL
Gallstones
Zhejiang UniversityN/AD (30)
DROPERIDOL
Ovarian Tumors
Zhejiang UniversityN/AD (30)
DROPERIDOL
Uterine Fibroids (Leiomyoma)
Zhejiang UniversityN/AD (30)
Fludarabine
Mesothelin-positive Advanced Malignant Solid Tumors
Zhejiang UniversityN/AD (30)
INDOMETACINUM
Urinary Bladder Disorder
Zhejiang UniversityN/AD (30)
INDOMETACINUM
Perioperative Anesthetic
Zhejiang UniversityN/AD (30)
NKG2D CAR-NK
Acute Myeloid Leukemia
Zhejiang UniversityN/AD (30)
Palonosetron
Gallstones
Zhejiang UniversityN/AD (30)
Palonosetron
Ovarian Tumors
Zhejiang UniversityN/AD (30)
Palonosetron
Uterine Fibroids (Leiomyoma)
Zhejiang UniversityN/AD (30)
177Lu-EB-FAPI
Advanced Pancreatic Cancer and Cholangiocarcinoma
Zhejiang UniversityP1NR (0)
il3 car t-cells
Acute Myeloid Leukemia
Zhejiang UniversityEarly P1NR (0)
Metabolically Armed Gpc3 Car-T Cells
Hepatocellular Carcinoma
Zhejiang UniversityEarly P1NR (0)
wtx212a
Neoplasm
Zhejiang UniversityEarly P1NR (0)
Showing 151 to 174 of 174 assets
PreviousPage 7 of 7Next